Solar urticaria

L12_SOLURTICARIA

photosensitivity disease: Photosensitivity refers to various symptoms, diseases and conditions caused or aggravated by exposure to sunlight.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — L56.3 Cause of death: ICD-10 — L56.3 2 out of 7 registries used, show all original rules.	58
4. Check minimum number of events None	58
5. Include endpoints None	58
6. Filter based on genotype QC (FinnGen only)	50

Control definitions (FinnGen only)

Control exclude: L12_RADIATIONRELATEDSKIN

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: L56
Name in latin: Urticaria solaris

NAME	L12_SOLURTICARIA
CONTROL_EXCLUDE	L12_RADIATIONRELATEDSKIN
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	L563
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	L563
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Solar urticaria based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	367	234	132
Only index persons	304	203	101
Unadjusted period prevalence (%)
Whole population	0.01	0.01	0.00
Only index persons	0.01	0.01	0.00
Median age at first event (years)
Whole population	30.97	35.89	22.21
Only index persons	37.92	40.56	32.62

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	50	38	12
Unadjusted period prevalence (%)	0.01	0.01	0.01
Median age at first event (years)	47.88	42.51	64.90

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
52: Matched controls
520

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

L56.3

ICD-10 Finland

Solar urticaria

+∞

74.4

L56.4

ICD-10 Finland

Polymorphous light eruption

121.2

9.8

J45.9

ICD-10 Finland

Asthma, unspecified

5.5

7.0

L50.8

ICD-10 Finland

Other urticaria

46.2

7.0

D07AC01

ATC

betamethasone; topical

4.6

6.9

112

XQ802

NOMESCO Finland

Epicutan test

15.1

6.4

L30.9

ICD-10 Finland

Dermatitis, unspecified

4.4

6.1

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3021589) Normoblasts [#/volume] in Blood

200

3.02

3.53

8.1

11.2

0.00

e9/l

-0.00

162

(42870588) Differential panel, method unspecified - Blood

146

2.37

2.35

6.3

6.4

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

5.40

2.12

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

5.40

2.12

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

5.40

2.12

1.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

3.19

1.96

1.0

1.1

—

(3013115) Eosinophils [#/volume] in Blood

254

2.16

1.78

6.6

7.1

0.20

0.18

e9/l

0.23

230

(3019198) Lymphocytes [#/volume] in Blood

245

2.12

1.75

6.5

7.1

2.39

1.92

e9/l

0.62

227

(3002030) Lymphocytes/Leukocytes in Blood

228

2.05

1.67

6.3

6.4

29.09

28.69

0.07

222

(3001604) Monocytes [#/volume] in Blood

239

2.04

1.63

6.5

7.2

0.60

0.56

e9/l

0.46

215

(3018010) Neutrophils/Leukocytes in Blood

231

2.00

1.57

6.3

6.1

58.00

57.47

0.09

222

(3006315) Basophils [#/volume] in Blood

241

2.01

1.57

6.5

7.1

0.05

0.04

e9/l

0.45

216

(40768443) Skin Pathology biopsy report

3.09

1.55

1.2

1.0

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

3.34

1.47

1.0

1.3

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

219

1.87

1.36

2.6

78.39

73.14

nmol/l

0.48

194

(3004716) Salmonella sp identified in Stool by Organism specific culture

2.69

1.34

1.2

1.6

—

(3018418) pH of Serum or Plasma

138

1.88

1.30

2.5

4.1

7.39

7.40

0.11

(3025941) Bacteria identified in Stool by Culture

2.58

1.28

1.0

1.2

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

2.80

1.24

1.2

1.5

0.24

0.23

g/l

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

2.80

1.24

1.0

1.3

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

2.65

1.18

1.2

1.5

1.54

1.21

g/l

—

(3019069) Monocytes/Leukocytes in Blood

230

1.72

1.06

6.5

6.3

7.73

8.26

0.56

220

(3026008) Bacteria identified in Urine by Culture

147

0.53

0.99

3.6

2.6

—

(40768804) Tissue Pathology biopsy report

196

1.65

0.95

2.6

1.8

—

(3007164) IgA [Mass/volume] in Serum or Plasma

115

1.71

0.92

1.9

1.4

2.56

2.04

g/l

—

(40758558) Short blood count panel - Blood

151

1.66

0.91

14.1

5.8

—

(3006504) Eosinophils/Leukocytes in Blood

228

1.61

0.88

6.7

6.3

2.52

2.69

0.23

216

(3016879) Cocaine [Presence] in Urine

0.00

0.81

0.0

1.5

—

(3000764) Benzodiazepines [Presence] in Urine

0.00

0.81

0.0

1.6

—

(3000492) Spirometry study

1.84

0.81

1.3

—

(3028300) Cannabinoids [Presence] in Urine

0.00

0.81

0.0

1.5

—

(3027944) Amphetamines [Presence] in Urine

0.00

0.81

0.0

1.5

—

(3027008) Opiates [Presence] in Urine

0.00

0.81

0.0

1.5

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1.80

0.80

2.6

5.5

226.00

244.15

u/l

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1.78

0.79

1.7

2.1

—

(40768797) Stomach Pathology biopsy report

1.77

0.79

1.1

1.3

—

(3002256) Pathology report gross observation

1.77

0.79

1.2

1.1

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

2.02

0.73

1.2

—

(4035726) Immunohistochemistry procedure

1.72

0.70

1.1

1.2

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

243

0.66

0.68

2.2

2.7

—

estimate

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1.75

0.66

1.6

8.7

0.98

1.06

mmol/l

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1.67

0.65

1.3

1.8

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

0.00

0.62

0.0

1.4

—

(3015736) pH of Urine

219

0.67

0.61

3.2

3.4

6.07

6.20

—

115

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

0.00

0.60

0.0

3.9

—

0.43

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

412

1.68

0.56

25.2

17.7

330.53

332.24

g/l

0.53

412

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1.56

0.53

1.0

1.8

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1.64

0.51

2.0

1.9

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1.60

0.51

2.0

1.8

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

198

1.39

0.49

2.5

2.0

105.15

100.18

pmol/l

0.16

104

(3020682) Albumin/Creatinine [Ratio] in Urine

134

1.40

0.44

4.6

3.8

1.76

10.91

mg/mmol

—

(3022313) Gas panel - Capillary blood

0.00

0.42

0.0

5.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

122

0.68

0.41

1.2

1.5

—

(40761536) Microorganisms panel - Urine sediment

1.43

0.39

1.8

2.5

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

347

1.35

0.36

2.8

3.7

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1.38

0.33

1.5

1.7

0.51

0.72

mg/l

—

(3022145) Colonoscopy Study observation

1.34

0.32

1.3

1.4

—

(3012516) Albumin [Mass/volume] in Urine

133

1.29

0.29

3.3

3.1

10.73

58.86

mg/l

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

162

1.27

0.28

2.3

2.9

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

125

0.75

0.26

4.8

3.6

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

0.70

0.26

1.2

1.5

—

(3044640) Blood type and Crossmatch panel - Blood

166

0.79

0.25

2.3

2.1

—

(3013512) EKG study

146

1.24

0.23

4.8

3.2

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.00

0.21

0.0

1.1

—

(3019230) Fractional oxyhemoglobin in Venous blood

0.00

0.21

0.0

2.4

—

58.55

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.21

0.0

1.3

—

(1761868) Lipid panel - Serum or Plasma

186

1.22

0.21

3.2

2.9

—

(3011648) Oxygen content in Venous blood

0.00

0.21

0.0

2.5

—

9.09

—

(3003740) Influenza virus B Ag [Presence] in Specimen

0.00

0.21

0.0

1.2

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.8

—

(3045716) Anion gap in Serum or Plasma by calculation

0.00

0.21

0.0

1.9

—

10.60

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

0.00

0.21

0.0

2.2

—

121.40

—

(3002523) Influenza virus A Ag [Presence] in Specimen

0.00

0.21

0.0

1.2

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.21

0.0

1.3

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

0.00

0.21

0.0

1.1

—

(4195642) Thrombophilia screening test

0.00

0.21

0.0

1.0

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

0.00

0.21

0.0

1.5

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

0.00

0.21

0.0

1.6

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

0.00

0.21

0.0

1.4

—

(21494755) Public health laboratory ask at order entry panel

1.28

0.21

1.2

1.4

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(4094501) Cardiovascular stress test using bicycle ergometer

0.00

0.21

0.0

1.1

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

0.00

0.21

0.0

1.2

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

0.00

0.21

0.0

1.5

—

(3028707) Methadone [Presence] in Urine by Screen method

0.00

0.20

0.0

1.4

—

(3042936) Bacteria identified in Isolate by Culture

0.71

0.18

2.4

2.5

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

0.75

0.17

1.7

450.67

475.20

pmol/l

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

270

1.17

0.15

5.1

4.3

7.30

6.35

mmol/l

1.04

246

(3003694) ABO and Rh group [Type] in Blood

148

0.84

0.15

1.8

1.5

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

158

0.84

0.14

2.2

3.3

8.50

43.74

ng/l

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1.19

0.10

2.4

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1.15

0.10

1.0

2.7

—

(36304419) Bacteria [Presence] in Urine

136

1.14

0.10

2.3

2.7

—

estimate

—

(3000850) Epithelial cells [#/volume] in Urine

113

0.86

0.09

1.4

2.2

6.74

5.17

e6/l

—

105

(3007853) Bacteria identified in Skin by Aerobe culture

0.76

0.08

1.4

1.7

—

(3019832) Treponema pallidum Ab [Presence] in Serum

0.87

0.07

2.3

1.9

—

(3023368) Bacteria identified in Blood by Culture

119

1.12

0.06

4.5

3.9

—

(3037467) Urinalysis macro (dipstick) panel - Urine

332

1.07

0.02

4.8

4.2

—

(40760892) CBC W Ordered Manual Differential panel - Blood

117

0.92

0.02

3.2

6.5

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

119

1.01

0.00

2.1

1.6

—

(3031040) Bacteria [#/volume] in Urine by Automated count

331

0.99

0.00

4.9

4.2

—

59.40

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1.07

0.00

2.7

2.5

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

124

0.96

0.00

1.8

2.1

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

114

0.96

0.00

3.9

3.5

754.18

1135.15

ng/l

0.35

102

(46235355) HIV 1 and 2 tests - Meaningful Use set

134

0.96

0.00

2.5

2.3

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

108

1.02

0.00

1.5

1.9

—

(3013290) Carbon dioxide [Partial pressure] in Blood

0.00

0.0

2.3

—

5.03

—

(3028433) Virus identified in Specimen by Culture

0.00

0.0

1.7

—

(3005570) Glucose [Moles/volume] in Urine

0.00

0.0

2.3

—

(3026389) Candida sp identified in Specimen by Organism specific culture

0.00

0.0

1.3

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.4

—

(3035637) Corticotropin [Mass/volume] in Plasma

0.00

0.0

1.7

—

18.67

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

0.00

0.0

1.6

—

(40768800) Prostate Pathology biopsy report

0.00

0.0

1.0

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.4

—

(3018333) Ribosomal P Ab [Presence] in Serum

0.00

0.0

1.4

—

(3021788) Differential panel - Synovial fluid

0.00

0.0

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.4

—

(3027315) Oxygen [Partial pressure] in Blood

0.00

0.0

2.3

—

9.81

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

0.00

0.0

1.0

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

7.4

—

37.39

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.0

—

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

0.00

0.0

1.5

—

13.57

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.4

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.4

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

0.00

0.0

2.6

—

(4281824) Cell count and differential, peritoneal fluid

0.00

0.0

1.0

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

0.00

0.0

1.0

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

0.00

0.0

1.3

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.00

0.0

1.0

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.4

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.4

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

0.00

0.0

1.5

—

117.17

—

(3035715) Granulocytes [#/volume] in Blood

0.00

0.0

3.1

—

3.93

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.00

0.0

1.4

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

0.00

0.0

1.1

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

105.00

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.3

—

(4268621) Lupus anticoagulant assay

0.00

-0.00

0.0

1.9

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.4

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

3.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

0.00

-0.00

0.0

1.0

—

(3032773) Endomysium IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.4

—

(3044242) Glucose [Moles/volume] in Arterial blood

0.00

-0.00

0.0

1.4

—

6.76

—

(36660697) Celiac disease serology panel - Serum

0.90

-0.00

1.2

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

0.00

-0.00

0.0

2.4

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

-0.00

0.0

1.4

—

(4211845) Urine protein measurement

0.00

-0.00

0.0

1.4

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.4

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.4

—

1.65

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

3.0

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

0.00

-0.00

0.0

1.0

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

3.0

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

0.00

-0.00

0.0

1.0

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

0.00

-0.00

0.0

3.0

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.4

—

(3044941) Cell count panel - Synovial fluid

0.00

-0.00

0.0

1.2

—

(1616796) Gas panel - Central venous blood

0.00

-0.00

0.0

1.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

0.00

-0.00

0.0

3.8

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1.04

-0.00

3.3

1.8

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.6

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

188.80

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.3

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

109.90

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

0.00

-0.00

0.0

1.0

—

(40768795) Lymph node Pathology biopsy report

0.00

-0.00

0.0

1.0

—

(3004809) Band form neutrophils/Leukocytes in Blood

0.00

-0.00

0.0

3.0

—

1.20

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.6

—

56.20

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.4

—

(44806420) Estimation of glomerular filtration rate

0.00

-0.00

0.0

2.2

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

Mortality – FinRegistry

↥

Association

Association between endpoint L12_SOLURTICARIA and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have L12_SOLURTICARIA.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: L12_SOLURTICARIA – Solar urticaria

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Solar urticaria

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints